Log in to save to my catalogue

Comparative Effectiveness Research for CAR-T Therapies in Multiple Myeloma: Appropriate Comparisons...

Comparative Effectiveness Research for CAR-T Therapies in Multiple Myeloma: Appropriate Comparisons...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2491080173

Comparative Effectiveness Research for CAR-T Therapies in Multiple Myeloma: Appropriate Comparisons Require Careful Considerations of Data Sources and Patient Populations

About this item

Full title

Comparative Effectiveness Research for CAR-T Therapies in Multiple Myeloma: Appropriate Comparisons Require Careful Considerations of Data Sources and Patient Populations

Publisher

Cham: Springer International Publishing

Journal title

Clinical drug investigation, 2021-03, Vol.41 (3), p.201-210

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

Background and Objective
Registrational trials for ciltacabtagene autoleucel [cilta-cel]) and idecabtagene vicleucel [ide-cel] chimeric antigen receptor T-cell (CAR-T) therapies were single-arm studies conducted with relapse refractory multiple myeloma (MM) patients who were triple-class-exposed (TCE) or triple-class-refractory (TCR). It is crit...

Alternative Titles

Full title

Comparative Effectiveness Research for CAR-T Therapies in Multiple Myeloma: Appropriate Comparisons Require Careful Considerations of Data Sources and Patient Populations

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2491080173

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2491080173

Other Identifiers

ISSN

1173-2563

E-ISSN

1179-1918

DOI

10.1007/s40261-021-01012-x

How to access this item